跳至主要内容
临床试验/NCT05062655
NCT05062655已完成不适用

Nterest of Drug Reconciliation to Ensure the Continuity of the Treatment at Discharge

Centre Hospitalier le Mans2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2021年11月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
2
主要终点
Value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment

研究概览

简要总结

From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient.

Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity.

The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management.

This new organisation is part of the policy of continuous improvement of the quality and safety of care

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • hospitalized patient
  • Patient with a drug treatment with a particular mode of supply
  • Paediatric patient or an adult patient.
  • First inpatient stay over the inclusion period from late 2021 to late 2022

排除标准

  • Patient under curatorship or guardianship
  • Patient residing abroad
  • No free, informed and written consent obtained

研究组 & 干预措施

Drug reconciliation

Experimental

Drug reconciliation and transmission to pharmacist

干预措施: Drug reconciliation (Other)

standard

No Intervention

结局指标

主要结局

Value of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment

时间窗: 1 month after inclusion

Value of coordinated pathway is evaluated by number of days of treatment interruption between patient discharge and provision of treatment to the patient

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Interest of Drug Reconciliation to Ensure the... | 临床试验